Enrolling by invitation

Immersive Virtual Reality Meditation in Voice Therapy

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Voice therapy

+ Meditation

+ Virtual Reality

BehavioralDevice
Who is being recruted

Laryngeal Diseases+5

+ Nervous System Diseases

+ Neurologic Manifestations

Over 18 Years
+3 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Placebo-Controlled
Interventional
Study Start: September 2025
See protocol details

Summary

Principal SponsorIcahn School of Medicine at Mount Sinai
Last updated: February 5, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 3, 2025

Actual date on which the first participant was enrolled.

The study is investigating if using guided meditation through immersive virtual reality (IVR) can improve voice therapy sessions. It focuses on 30 participants who will use the TRIPP application with the Meta Quest 2 virtual reality headset. This technology is famous for providing calming or focusing meditation experiences. The goal is to see if starting voice therapy with these meditations can help people learn and remember the therapy techniques better. This research is important because stress and anxiety can make voice therapy less effective, and finding ways to enhance therapy through IVR could help people manage their vocal issues more successfully. In the study, participants will use the virtual reality headset at the beginning of their voice therapy sessions to engage in guided meditation. This approach aims to improve their attention, self-control, and reduce excessive strain on their voices. The study will evaluate how these meditations impact vocal production and therapy engagement. Although specific risks or benefits are not mentioned, the research hopes to show that incorporating meditation in this way can enhance therapy outcomes by helping participants focus better and manage their stress, potentially leading to better voice control and therapy results.

Official TitleImmediate and Cumulative Effects of Meditation on Voice Therapy Using Immersive Virtual Reality (IVR)
NCT07176013
Principal SponsorIcahn School of Medicine at Mount Sinai
Last updated: February 5, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

60 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Laryngeal DiseasesNervous System DiseasesNeurologic ManifestationsOtorhinolaryngologic DiseasesRespiratory Tract DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsVoice Disorders

Criteria

1 inclusion criteria required to participate
Must have availability to participate for entire course of 5 consistent weeks

2 exclusion criteria prevent from participating
Anyone not meeting inclusion criteria

Presence of any additional medical condition significantly affecting: Respiratory function (e.g., advanced lung disease), Laryngeal function (e.g., status-post deep brain stimulation), Lingual function, Velopharyngeal function (e.g., laryngectomy)

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

33.333% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental
Those who receive meditation in immersive virtual reality prior to voice therapy each of the 4 sessions.

Group II

Experimental
Those who receive meditation with verbal guidance only prior to voice therapy each of the 4 sessions.

Group III

Sham
Those who receive standard voice therapy with no meditation.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Mount Sinai Downtown Union Square

New York, United StatesOpen Mount Sinai Downtown Union Square in Google Maps
Enrolling by invitationOne Study Center